当前位置:首页 - 行情中心 - 贝瑞基因(000710) - 财务分析 - 利润表

贝瑞基因

(000710)

30.90

-1.03  (-3.23%)

今开:31.80最高:31.80成交:2.06万手 市盈:0.00 上证指数:2991.05   -0.56%2019-10-15
昨收:31.93 最低:30.86 换手:0.00%振幅:0.00 深证指数:9671.73  -1.17%15:02:03

集合

竞价

利润表

按照会计年度查询:
报告期2019-06-302018-09-302018-06-302018-03-31
一、营业总收入753,237,670.261,028,243,410.55644,500,047.78297,185,149.31
营业收入753,237,670.261,028,243,410.55644,500,047.78297,185,149.31
二、营业总成本542,621,045.95751,900,989.94471,438,854.75218,914,759.43
营业成本292,601,792.94429,016,280.67279,352,346.86134,353,702.97
营业税金及附加2,748,183.15,186,068.163,185,161.431,300,226.19
销售费用140,453,080.21184,527,432.95109,817,510.4351,458,952.14
管理费用54,998,712.5173,225,317.0578,943,857.6934,750,360.77
财务费用-1,619,333.322,705,637.92-268,877.91-4,823,547.44
资产减值损失--1,374,380.24408,856.251,875,064.79
三、其他经营收益344,006.052,794,207.242,063,021.47--
允许价值变动净收益--------
投资净收益70,847,271.42-1,210,308.75-6,767,767.55-373,081.83
联营、合营企业投资收益-22,802,968.08-7,210,308.75---373,081.83
汇兑净收益--------
四、营业利润280,139,221.07281,611,761.86171,579,502.2678,094,808.05
营业外收入582,767.58525,486.03352,096.25108,263.6
营业外支出82,673.53396,403.8331,217.75269,541.02
非流动资产处置净损失--------
五、利润总额280,639,315.12281,740,844.09171,600,380.7677,933,530.63
所得税31,783,668.8243,964,839.925,885,374.1811,963,700.27
未确认的投资损失--------
六、净利润(百万元)250.83167.69268.09238.99
少数股东损益-1,970,585.71-1,210,228.51-153,853.84302,651.1
归属于母公司股东的净利润250,826,232.01238,986,232.7145,868,860.4265,667,179.26
七、每股收益0.710.67----
基本每股收益0.710.670.410.19
稀释每股收益0.710.670.410.19
TOP↑